Li Z - Search Results

1

SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination.

Lv T, He D, Zhang X, Guo X, Li Z, Zhang A, Fan B, Wang Z. Lv T, et al. Among authors: li z. Aging (Albany NY). 2022 Dec 23;14(24):10050-10066. doi: 10.18632/aging.204443. Epub 2022 Dec 23. Aging (Albany NY). 2022. PMID: 36566018 Free PMC article.

2

Role of exosomes in prostate cancer bone metastasis.

Lv T, Li Z, Wang D, Guo X, Zhang X, Cao J, Wang Z. Lv T, et al. Among authors: li z. Arch Biochem Biophys. 2023 Oct 15;748:109784. doi: 10.1016/j.abb.2023.109784. Epub 2023 Oct 8. Arch Biochem Biophys. 2023. PMID: 37816420 Review.

3

Esophageal cancer cell-derived small extracellular vesicles decrease circulating Tfh/Tfr via sEV-PDL1 to promote immunosuppression.

Li Z, Zhang Y, Hao H, Chen L, Lv T, Zhang X, Qi Y, Wang Z. Li Z, et al. Cancer Immunol Immunother. 2023 Dec;72(12):4249-4259. doi: 10.1007/s00262-023-03561-w. Epub 2023 Nov 9. Cancer Immunol Immunother. 2023. PMID: 37943341 Free PMC article.

4

Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.

Cao W, Zhang X, Li R, Li Z, Lu A, Yu F, Sun L, Wang J, Wang Z, He H. Cao W, et al. Among authors: li z, li r. J Control Release. 2024 Apr;368:52-65. doi: 10.1016/j.jconrel.2024.02.025. Epub 2024 Feb 21. J Control Release. 2024. PMID: 38368946

5

Distinguishing optimal candidates for primary tumor resection in patients with metastatic lung adenocarcinoma: A predictive model based on propensity score matching.

Qi Y, Guo X, Li Z, Ren B, Wang Z. Qi Y, et al. Among authors: li z. Heliyon. 2024 Mar 26;10(7):e27768. doi: 10.1016/j.heliyon.2024.e27768. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38690000 Free PMC article.

6

Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.

Guo Y, Qian R, Li Z, Lv T, Yang C, Li W, Pan T, Hou X, Wang Z. Guo Y, et al. Among authors: li z, li w. Life Sci. 2024 Jul 1;348:122687. doi: 10.1016/j.lfs.2024.122687. Epub 2024 May 7. Life Sci. 2024. PMID: 38718856

7

Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation.

Cao W, Zhang X, Feng Y, Li R, Lu A, Li Z, Yu F, Sun L, Wang J, Wang Z, He H. Cao W, et al. Among authors: li z, li r. ACS Nano. 2024 Jul 2;18(26):17267-17281. doi: 10.1021/acsnano.4c04901. Epub 2024 Jun 13. ACS Nano. 2024. PMID: 38871478

8

Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma.

Wang DH, Ye LH, Ning JY, Zhang XK, Lv TT, Li ZJ, Wang ZY. Wang DH, et al. Front Mol Biosci. 2024 Jun 27;11:1301099. doi: 10.3389/fmolb.2024.1301099. eCollection 2024. Front Mol Biosci. 2024. PMID: 38993839 Free PMC article.

9

Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy.

Guo Y, Lv T, Li Z, Wei X, Yang C, Li W, Hou X, Wang Z, Qian R. Guo Y, et al. Among authors: li z, li w. J Nanobiotechnology. 2024 Jul 20;22(1):430. doi: 10.1186/s12951-024-02719-7. J Nanobiotechnology. 2024. PMID: 39033108 Free PMC article.

10

Esophageal squamous cell carcinoma derived sEV-PDL1 exhausts CD8⁺T cells to promote immunosuppression.

Li Z, Zhang X, Qi Y, Wang Z. Li Z, et al. Mol Immunol. 2025 Jan 10;178:12-19. doi: 10.1016/j.molimm.2025.01.001. Online ahead of print. Mol Immunol. 2025. PMID: 39798225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,900 results

Search Page

Filters